| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Alx Oncology Holdings Inc. (ALXO) have been net sellers, shedding 2,803 shares worth roughly $5K on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.45M | $10.90M | - | |
| CEO | 294.4K | $379.7K | - | |
| VP | 87.8K | $113.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | Rekha Hemrajani | Director | Buy | 30,000 | $1.55 | $46,404.00 | +1,000% | -38.0% | -27.7% | |
| Aug 14, 2024 | Shelly Pinto69 | SVP, Finance and CAO | Sell | 564 | $2.58 | $1,455.12 | -0.6% | -48.1% | -74.6% | |
| Aug 14, 2024 | Sophia Randolph88 | Chief Medical Officer | Sell | 1,365 | $2.58 | $3,521.70 | -0.4% | -48.1% | -74.6% | |
| Aug 14, 2024 | Jaume Pons89 | President & CSO | Sell | 1,937 | $2.58 | $4,997.46 | -0.3% | -48.1% | -74.6% | |
| Jul 11, 2024 | Jaume Pons89 | President & CSO | Sale+OE10b5-1 | 20,000 | $7.90 | $158,076.00 | -3.3% | -79.0% | -93.7% | |
| Jul 5, 2024 | Shelly Pinto69 | SVP, Finance and CAO | Sell | 1,823 | $5.50 | $10,025.22 | -1.9% | -68.4% | -91.9% | |
| Jul 1, 2024 | Shelly Pinto69 | SVP, Finance and CAO | Sell | 1,373 | $5.82 | $7,989.21 | -1.4% | -69.6% | -92.8% | |
| Jul 1, 2024 | Sophia Randolph88 | Chief Medical Officer | Sell | 3,273 | $5.82 | $19,044.93 | -1.0% | -69.6% | -92.8% | |
| Jul 1, 2024 | Jaume Pons89 | President & CSO | Sell | 10,758 | $5.82 | $62,598.65 | -1.8% | -69.6% | -92.8% | |
| Jun 13, 2024 | Peter S Garcia81 | Chief Financial Officer | Buy | 12,000 | $8.53 | $102,338.40 | +10.9% | -74.2% | -93.9% |